https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/issue/feed One Health & Risk Management 2026-05-15T11:26:34+00:00 Burduniuc Olga olga.burduniuc@ansp.gov.md Open Journal Systems One Health & Risk Management is a biannual scientific journal for specialists in medical and biological sciences, which was founded in 2019 within the Moldavian Biosafety and Biosecurity Asociation (MDBBA). The journal accepts submissions in Romanian, English, French and Russian, in accordance with current international standards and guidelines. Therefore, One Health & Risk Management Journal will support and publish manuscripts based on scientific evidence on human, animal and environmental health. https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/1014 One Health: a strategic imperative for the future of Public Health 2026-05-12T11:28:30+00:00 Simona VILLANI olgaburduniuc3@gmail.com <p>According to the World Health Organization “One Health is an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals and ecosystems. (…) By linking humans, animals and the environment, One Health can help to address the full spectrum of disease control – from prevention to detection, preparedness, response and management – and contribute to global health security (WHO-One Health)”.<br>It is therefore evident that advancing an integrated and forward-looking vision of health is no longer, but imperative. The One Health approach provides a powerful and necessary framework for addressing the multifaceted nature of today’s public health challenges, from emerging and re-emerging infectious diseases to the far-reaching consequences of environmental change.<br>In this context, One Health &amp; Risk Management stands out as a timely and essential academic platform, committed to fostering interdisciplinary research and meaningful scientific exchange. By bridging disciplines and uniting expertise, this journal plays a critical role in generating robust, evidence-based solutions and in strengthening the connection between research, practice, and policy.<br>From the standpoint of biostatistics and epidemiology, such initiatives are strategically crucial. Rigorous research methodologies grounded in good epidemiological practice, high-quality data, and robust analytical methods constitute the pillars for translating evidence into resilient, responsive, and sustainable health systems. Platforms such as this journal are instrumental in advancing these objectives and in shaping the future of public health.<br>I warmly commend the editorial team for their vision, leadership, and commitment to scientific excellence. I am confident that One Health &amp; Risk Management will establish itself as a leading voice in the global public health community, driving innovation, fostering collaboration, and contributing meaningfully to a healthier and more secure world.</p> 2026-03-31T00:00:00+00:00 Copyright (c) https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/902 Strategies for risk assessment in medication management: A systematic review of their impact on patient safety and operational efficiency 2026-05-15T11:26:06+00:00 Tosi RAHMADDIAN tosi_rahmaddian@fkm.unbrah.ac.id Sevilla UKHTIL HUVAID sevillaukhtilhuvaid@fkm.unbrah.ac.id Hilda HIDAYAT hildahidayat@fkm.unbrah.ac.id Yulianita YULIANITA yulianitaa@fkm.unbrah.ac.id Sri OKTARINA srioktarina@fkm.unbrah.ac.id <p><strong>Introduction.&nbsp; </strong><span style="font-weight: 400;">Medication management is a complex, high-risk component of healthcare and remains vulnerable to errors that might affect patient safety and operational efficiency.</span> <span style="font-weight: 400;">This systematic review aimed to evaluate risk assessment strategies used in medication management and to synthesise evidence regarding their impact on patient safety and operational performance.</span><span style="font-weight: 400;"><br></span><strong>Materials and methods.</strong><span style="font-weight: 400;"> A systematic review was conducted following PRISMA 2020 guidelines. Comprehensive searches of the Scopus and PubMed databases identified peer-reviewed studies published between 2020 and 2025. Using the PICOS framework, eligible studies evaluated risk assessment strategies within medication-use processes and reported patient-related safety and/or efficiency outcomes. Data were analysed through thematic synthesis.</span><span style="font-weight: 400;"><br></span><strong>Results.</strong><span style="font-weight: 400;"> Sixteen studies met the inclusion criteria. Proactive risk assessment strategies - notably Failure Mode and Effects Analysis and its variants - were widely implemented across medication-use processes, particularly in high-risk settings. Their use improved the identification and prioritisation of medication-related risks, reduced error rates or risk scores, bolstered compliance with safety protocols, and optimised workflow organisation and resource allocation. Technology-driven tools further enhanced effectiveness by enabling standardisation and continuous monitoring.</span><span style="font-weight: 400;"><br></span><strong>Conclusions. </strong><span style="font-weight: 400;">Structured risk assessment strategies measurably improve patient safety and operational efficiency in medication management. Further longitudinal and comparative research is required to evaluate long-term clinical and economic</span> <span style="font-weight: 400;">outcomes.</span></p> 2026-03-31T00:00:00+00:00 Copyright (c) 2026 Tosi Rahmaddian, Sevilla Ukhtil Huvaid Ukhtil Huvaid, Hilda Hidayat , Yulianita Yulianita, Sri Oktarina https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/965 Global seroprevalence of anti-HEV antibodies in pregnant women: a systematic meta-analysis 2026-05-15T11:25:15+00:00 Octavian SAJIN octavian.sajin@yahoo.com Adela TURCANU adela.turcanu@usmf.md Veaceslav GUTU veaceslav.gutu@ansp.gov.md Nina IZIUMOV nina.iziumov@ansp.gov.md Valentina BLAJ valentina.blaj@ansp.gov.md <p><strong>Introduction. </strong><span style="font-weight: 400;">Hepatitis E virus (HEV) represents a significant public health concern during pregnancy, being associated with severe maternal and fetal complications. This meta-analysis aimed to estimate the global seroprevalence of anti-HEV IgG and IgM antibodies among pregnant women.</span></p> <p><strong>Materials and methods. </strong><span style="font-weight: 400;">A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Observational studies were identified in PubMed, Scopus, and Web of Science. Pooled seroprevalence estimates were calculated using a random-effects model. Heterogeneity was assessed using Cochran’s Q and the I² statistic, while publication bias was evaluated by funnel plots and Egger’s regression test.</span></p> <p><strong>Results. </strong><span style="font-weight: 400;">Thirty studies from diverse geographic regions were included. The pooled global seroprevalence of anti-HEV IgG was 11.76% (95% CI: 9.45–14.54), indicating widespread prior exposure. Anti-HEV IgM seroprevalence, reflecting recent infection, was 1.07% (95% CI: 0.61–1.86). Substantial heterogeneity was observed for both markers (I² &gt; 95%), reflecting marked regional variability. No statistically significant small-study effects were detected by Egger’s regression (p &gt; 0.05).</span></p> <p><strong>Conclusions. </strong><span style="font-weight: 400;">HEV exposure among pregnant women is common globally, with pronounced regional differences, whereas recent infection appears relatively rare at the global level. These findings highlight the need for region-specific surveillance, improved diagnostic standardization, and targeted preventive strategies to reduce HEV-related risks during pregnancy.</span></p> 2026-03-31T00:00:00+00:00 Copyright (c) 2026 Octavian Sajin, Adela Turcanu, Veaceslav Gutu, Nina Iziumov, Valentina Blaj https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/963 Radon risk communication, awareness and perception: results of a national public opinion survey in the Republic of Moldova 2026-05-15T11:25:39+00:00 Liuba CORETCHI liuba.koretski@ansp.gov.md Ala OVERCENCO ala.overcenco@ansp.gov.md Aurelia ABABII aurelia.ababii@ansp.gov.md Mariana GINCU mariana.gincu@ms.gov.md Angela CAPATINA angela.capatina@ansp.gov.md <p><strong>Introduction</strong><span style="font-weight: 400;"> Radon is a naturally occurring radioactive gas, recognized as a leading cause of lung cancer among non-smokers. The level of public radon awareness remains low in many countries. The study presents the results of a public opinion survey in the Republic of Moldova within the IAEA STEAM Project (RER9153), </span><em><span style="font-weight: 400;">aiming to</span></em><span style="font-weight: 400;"> assess public awareness, risk perception, and willingness to undertake radon mitigation measures.&nbsp;</span></p> <p><strong>Material and methods </strong><span style="font-weight: 400;">A structured questionnaire was administered to 391 adults across 20 districts and 2 municipalities during December 2020–February 2021. Statistical analysis was used to assess associations among radon knowledge levels and socio-demographic variables.&nbsp;</span></p> <p><strong>Results</strong><span style="font-weight: 400;"> showed that 75.4% of respondents knew little or nothing about radon, although 64.5% considered home radon testing a priority. More than half were unaware of how testing is performed, and approximately 30% believed that ventilation could replace testing. While 84.9% correctly linked radon to lung cancer, many associated it with unrelated diseases. Family doctors and public health institutions were the most trusted sources but were rarely used, whereas the internet and social media were frequently used but were less trusted. Radon was perceived as posing a lower risk than nuclear accidents and food contamination.&nbsp;</span></p> <p><strong>Conclusions </strong><span style="font-weight: 400;">The findings revealed significant knowledge gaps and misconceptions among communities, underscoring the need for targeted, evidence-based risk communication strategies using trusted healthcare channels to promote awareness and action regarding indoor radon exposure.</span></p> 2026-03-31T00:00:00+00:00 Copyright (c) 2026 Liuba Corețchi, Ala Overcenco, Aurelia Ababii, Mariana Gîncu, Angela Capațîna https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/856 Informed consent: challenges and perspectives of patients and healthcare providers in Georgia 2026-05-13T11:25:26+00:00 Nino GONGLADZE gongladzeen@gmail.com Nato PITSKHELAURI nato.pitskhelauri@tsu.ge <p><strong>Background.</strong><span style="font-weight: 400;"> The informed consent process is crucial in ensuring patient autonomy and ethical medical practice. The study aimed to assess understanding, experiences, and perceptions of informed consent among hospital personnel and the general population in Georgia, and to identify key challenges in its implementation.&nbsp;</span></p> <p><strong>Material and methods.</strong><span style="font-weight: 400;"> Two structured questionnaires were developed, one targeting healthcare professionals and the other the general population. The surveys explored respondents' knowledge, experiences, and opinions on informed consent. Data were analyzed to identify key topics and areas for improvement in the process.</span></p> <p><strong>Results.</strong><span style="font-weight: 400;"> Among the general population, 68.8% reported receiving the informed consent form before medical services, while only 50.2% were informed of their right to accept or decline it. Nearly half (48.3%) reported misunderstandings of information provided by doctors. For hospital personnel, while there was unanimous agreement on the necessity of obtaining informed consent before procedures, only 59.3% demonstrated full understanding of required consent content, and only 10.2% correctly identified who else can sign the consent form. Notably, only 6.8% comprehended the nuances of verbal consent.</span></p> <p><strong>Conclusions. </strong><span style="font-weight: 400;">Significant gaps persist in the informed consent process in Georgia, including communication barriers, time constraints, and inconsistent understanding among patients and providers. Enhanced training, clear communication strategies, standardized practices, and the integration of technology are recommended to improve the informed consent process.</span></p> 2026-03-31T00:00:00+00:00 Copyright (c) 2026 Nino Gongladze, Nato Pitskhelauri https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/889 Growth patterns in duchenne muscular dystrophy 2026-05-15T11:26:34+00:00 Iulia RODOMAN iulia.rodoman@gmail.com Victoria SACARA victoriasacara@hotmail.com Ina PALII ina.palii@usmf.md <p><strong>Introduction.</strong><span style="font-weight: 400;"> Duchenne muscular dystrophy (DMD) is a genetic disorder that significantly affects growth and development, characterised by progressive degeneration of skeletal and cardiac muscles, typically beginning in early childhood, between 2 and 5 years old.&nbsp;</span></p> <p><strong>Purpose of the study.</strong><span style="font-weight: 400;"> To assess longitudinal growth parameters (height, weight, BMI) in children with genetically confirmed DMD compared with healthy age- and sex-matched controls.</span></p> <p><strong>Materials and methods.</strong><span style="font-weight: 400;"> A total of 100 children were included: 50 with DMD and 50 controls. Anthropometric data were collected at 3 follow-up visits over a 12-month period and analysed using Microsoft Excel (Office 365) and StatTech v.4.6.3.</span></p> <p><strong>Results.</strong><span style="font-weight: 400;"> Children with DMD exhibited impaired growth compared with controls:&nbsp; lower height (median 1.25 m [1.10–1.44] vs 1.56 m [1.37–1.68]; p&lt;0.001), lower height z-score (−0.95±1.57 vs 0.42±1.41; p&lt;0.001), and lower height percentile (16.0 vs 63.7; p&lt;0.001). Body weight was also lower (27.7 kg [18.5–34.0] vs 46.0 kg [29.3–58.0]; p&lt;0.001), with reduced weight z-score (−0.61 vs 0.57; p=0.003) and percentile (26.9 vs 71.6; p=0.003). BMI was lower in the DMD group (15.9 vs 18.4 kg/m²; p=0.007), whereas BMI z-scores and percentiles did not differ significantly (p&gt;0.05). Growth velocity declined over time (height increase of 0.03 m from Visit 1 to Visit 2 vs 0.01 m from Visit 2 to Visit 3; p&lt;0.01). Among patients with DMD stratified by duration of deflazacort treatment, the &gt;12-month subgroup showed the greatest growth gains, although differences between subgroups were not statistically significant.</span></p> <p><strong>Conclusions.</strong><span style="font-weight: 400;"> Children with DMD&nbsp; had a delayed growth compared with their peers, with progressive slowing over time. Regular auxological monitoring is essential, and further studies are needed to clarify the effects of corticosteroid therapy.</span></p> 2026-03-31T00:00:00+00:00 Copyright (c) 2026 Iulia Rodoman, Victoria Sacară, Ina Palii https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/998 Personalized approach to non-communicable disease prevention in the working population 2026-05-15T11:24:56+00:00 Lyubov VLASYK lyubov.vlasyk@gmail.com Leonid VLASYK vlasyk.lyubov@bsmu.edu.ua Nataliia RYNHACH vlasyk.lyubov@bsmu.edu.ua <p><strong>Introduction. </strong><span style="font-weight: 400;">Effective prevention of noncommunicable diseases (NCDs) requires shifting from generalized advice to personalized interventions.</span></p> <p><strong>Aim.</strong><span style="font-weight: 400;"> To develop and justify personalized approaches to NCD prevention for the working population, by identifying key behavioral predictors, focusing on the interplay between diet, physical activity, and social barriers.&nbsp;</span></p> <p><strong>Materials and Methods.</strong><span style="font-weight: 400;"> A mixed-methods study was conducted, integrating quantitative survey data (pre-pandemic baseline, </span><em><span style="font-weight: 400;">N</span></em><span style="font-weight: 400;"> = 1252) and qualitative interviews with market employees in early January 2026 (</span><em><span style="font-weight: 400;">n</span></em><span style="font-weight: 400;"> = 30). Statistical analysis included Odds Ratios (OR), Sensitivity (Se), Specificity (Sp), and Likelihood Ratios (LR).</span></p> <p><strong>Results.</strong><span style="font-weight: 400;"> Individual Nutritional Control (INC) and Daily Physical Exercise (DPE) were identified as core markers of health engagement. DPE demonstrated exceptional diagnostic power in ruling out perceived physical inactivity (LR– 0.05, Positive Predictive Value, PPV 0.93). Absence of INC was associated with 4-fold higher odds of physical inactivity (OR 4.03; 95% CI 2.83–5.72). Qualitative data from 2026 revealed "preventive inertia" and a shift toward telemedicine and "proxy" family consultations under extreme environmental stress and power outages.</span></p> <p><strong>Conclusions.</strong><span style="font-weight: 400;"> A personalized approach involves identifying "leading components," such as DPE, to catalyze broader lifestyle changes. Integration of tailored health coaching and workplace wellness programs is essential for sustainable NCD prevention.</span></p> 2026-04-23T00:00:00+00:00 Copyright (c) 2026 Lyubov VLASYK, Leonid VLASYK, Nataliia RYNHACH